Keywords: merck, co, first, taste, life, after, vioxx

Merck & Co's first taste of life after Vioxx; earnings per share to take substantial hit

Article | 20 December 2004

Print This

US drug major Merck & Co is seemingly firmly set onto a path of declining profits over the next few years, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in